Miri Wernli
President bei MIND MEDICINE (MINDMED) INC.
Vermögen: 767 163 $ am 31.03.2024
Profil
Miri Halperin Wernli is the founder of Melodiol Global Health Ltd., which was founded in 2015.
She held the title of Group CEO, Managing Director & Executive Director at the company.
Currently, Dr. Wernli is the Executive President at Mind Medicine (MindMed), Inc., starting in 2020.
In her former position, she was the Vice President at Actelion Pharmaceuticals US, Inc. from 2007 to 2016.
Dr. Wernli has an MBA from Stanford University and a doctorate from the University of Geneva.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.02.2024 | 81 353 ( 0,12% ) | 764 718 $ | 31.03.2024 | |
| 29.03.2023 | 750 000 ( 0,18% ) | 2 445 $ | 31.03.2024 |
Aktive Positionen von Miri Wernli
| Unternehmen | Position | Beginn |
|---|---|---|
| MIND MEDICINE (MINDMED) INC. | President | 01.02.2021 |
Ehemalige bekannte Positionen von Miri Wernli
| Unternehmen | Position | Ende |
|---|---|---|
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01.01.2016 |
| MELODIOL GLOBAL HEALTH LIMITED | Chief Executive Officer | 15.08.2020 |
Ausbildung von Miri Wernli
| Stanford University | Masters Business Admin |
| University of Geneva | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MELODIOL GLOBAL HEALTH LIMITED | Health Technology |
| MIND MEDICINE (MINDMED) INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
